References
Ward EM, DeSantis CE, Lin CC, et al. Cancer statistics: breast cancer in situ. CA Cancer J Clin. 2015;65(6):481–95.
Gradishar WJ, Anderson BO, Balassanian R, et al. Breast cancer, version 4.2017, NCCN clinical practice guidelines in oncology. 2018;16(3):310.
Solin LJ. Management of ductal carcinoma in situ (DCIS) of the breast: present approaches and future directions. Curr Oncol Rep. 2019;21(4):33.
Groen EJ, Elshof LE, Visser LL, et al. Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS). The Breast. 2017;31:274–83.
Kanbayashi C, Thompson AM, Hwang E-SS, et al. The international collaboration of active surveillance trials for low-risk DCIS (LORIS, LORD, COMET, LORETTA). J Clin Oncol. 2019;37(15_suppl):TPS603-TPS603.
Wapnir I, DeMartini W, Allison K, et al. Abstract OT3-09-04: a randomized phase II study comparing surgical excision versus Neadjuvant radiotherapy followed by delayed surgical excision of Ductal carcinoma In Situ (NORDIS). Cancer Res. 2020;80(4 Supplement):OT3-09-04-OT03-09-04.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Disclosure
The authors declare they have no conflicts of interest and nothing to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Rossi, A.J., Verbus, E.A., Horst, K. et al. Surgical Excision Versus Neoadjuvant Radiotherapy Followed by Delayed Surgical Excision of Ductal Carcinoma In Situ (NORDIS). Ann Surg Oncol 29, 1528–1529 (2022). https://doi.org/10.1245/s10434-021-10552-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-10552-7